Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$0.5 - $0.88 $7,441 - $13,096
-14,882 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$0.58 - $1.09 $8,631 - $16,221
14,882 New
14,882 $9,000
Q3 2021

Nov 15, 2021

SELL
$0.93 - $1.18 $121,212 - $153,796
-130,336 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$1.19 - $2.06 $133,341 - $230,827
112,052 Added 612.84%
130,336 $155,000
Q1 2021

May 17, 2021

BUY
$1.62 - $3.05 $29,620 - $55,766
18,284 New
18,284 $38,000
Q1 2019

May 15, 2019

SELL
$4.84 - $9.07 $65,824 - $123,352
-13,600 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$4.21 - $14.28 $57,256 - $194,208
13,600 New
13,600 $85,000

Others Institutions Holding ECOR

About electroCore, Inc.


  • Ticker ECOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 71,176,896
  • Market Cap $455M
  • Description
  • electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....
More about ECOR
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.